Literature DB >> 26245718

Magnetic hyaluronic acid nanospheres via aqueous Diels-Alder chemistry to deliver dexamethasone for adipose tissue engineering.

Yang Jia1, Ming Fan1, Huinan Chen1, Yuting Miao1, Lian Xing1, Bohong Jiang1, Qifan Cheng1, Dongwei Liu1, Weikang Bao1, Bin Qian1, Jionglu Wang1, Xiaodong Xing1, Huaping Tan2, Zhonghua Ling3, Yong Chen3.   

Abstract

Biopolymer-based nanospheres have great potential in the field of drug delivery and tissue regenerative medicine. In this work, we present a flexible way to conjugate a magnetic hyaluronic acid (HA) nanosphere system that are capable of vectoring delivery of adipogenic factor, e.g. dexamethasone, for adipose tissue engineering. Conjugation of nanospheres was established by aqueous Diels-Alder chemistry between furan and maleimide of HA derivatives. Simultaneously, a furan functionalized dexamethasone peptide, GQPGK, was synthesized and covalently immobilized into the nanospheres. The magnetic HA nanospheres were fabricated by encapsulating super-paramagnetic iron oxide nanoparticles, which exhibited quick magnetic sensitivity. The aqueous Diels-Alder chemistry made nanospheres high binding efficiency of dexamethasone, and the vectoring delivery of dexamethasone could be easily controlled by a external magnetic field. The potential application of the magnetic HA nanospheres on vectoring delivery of adipogenic factor was confirmed by co-culture of human adipose-derived stem cells (ASCs). In vitro cytotoxicity tests demonstrated that incorporation of dexamethasone into magnetic HA nanospheres showed high efficiency to promote ASCs viabilities, in particular under a magnetic field, which suggested a promising future for adipose regeneration applications.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biopolymers; Drug delivery; Magnetic nanoparticles; Nanospheres; Tissue engineering

Mesh:

Substances:

Year:  2015        PMID: 26245718     DOI: 10.1016/j.jcis.2015.07.062

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  7 in total

1.  Dose-, treatment- and time-dependent toxicity of superparamagnetic iron oxide nanoparticles on primary rat hepatocytes.

Authors:  Kurtulus Gokduman; Furkan Bestepe; Lei Li; Martin L Yarmush; O Berk Usta
Journal:  Nanomedicine (Lond)       Date:  2018-06       Impact factor: 5.307

Review 2.  Iron Oxide Nanoparticles in Regenerative Medicine and Tissue Engineering.

Authors:  Ralf P Friedrich; Iwona Cicha; Christoph Alexiou
Journal:  Nanomaterials (Basel)       Date:  2021-09-08       Impact factor: 5.719

Review 3.  Hyaluronic Acid: Redefining Its Role.

Authors:  G Abatangelo; V Vindigni; G Avruscio; L Pandis; P Brun
Journal:  Cells       Date:  2020-07-21       Impact factor: 6.600

Review 4.  Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems.

Authors:  Vijay Sagar Madamsetty; Reza Mohammadinejad; Ilona Uzieliene; Noushin Nabavi; Ali Dehshahri; Jomarien García-Couce; Shima Tavakol; Saeid Moghassemi; Arezoo Dadashzadeh; Pooyan Makvandi; Abbas Pardakhty; Abbas Aghaei Afshar; Ali Seyfoddin
Journal:  ACS Biomater Sci Eng       Date:  2022-04-19

Review 5.  Current Therapeutic Strategies for Adipose Tissue Defects/Repair Using Engineered Biomaterials and Biomolecule Formulations.

Authors:  Christopher M Mahoney; Cayla Imbarlina; Cecelia C Yates; Kacey G Marra
Journal:  Front Pharmacol       Date:  2018-05-17       Impact factor: 5.810

Review 6.  Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity.

Authors:  Laís Salomão Arias; Juliano Pelim Pessan; Ana Paula Miranda Vieira; Taynara Maria Toito de Lima; Alberto Carlos Botazzo Delbem; Douglas Roberto Monteiro
Journal:  Antibiotics (Basel)       Date:  2018-06-09

Review 7.  Dexamethasone Conjugates: Synthetic Approaches and Medical Prospects.

Authors:  Natallia V Dubashynskaya; Anton N Bokatyi; Yury A Skorik
Journal:  Biomedicines       Date:  2021-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.